Short Bowel Syndrome (SBS) Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

The global market for Short Bowel Syndrome (SBS) Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome (SBS) Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Short Bowel Syndrome (SBS) Drugs by region & country, by Type, and by Sale Channel.

The Short Bowel Syndrome (SBS) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome (SBS) Drugs.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in country level. It provides sigmate data by Type, and by Sale Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Short Bowel Syndrome (SBS) Drugs Product Introduction
    1.2 Global Short Bowel Syndrome (SBS) Drugs Market Size Forecast
        1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030)
        1.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume (2019-2030)
        1.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Price (2019-2030)
    1.3 Short Bowel Syndrome (SBS) Drugs Market Trends & Drivers
        1.3.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
        1.3.2 Short Bowel Syndrome (SBS) Drugs Market Drivers & Opportunity
        1.3.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
        1.3.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Short Bowel Syndrome (SBS) Drugs Players Revenue Ranking (2023)
    2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Company (2019-2024)
    2.3 Global Short Bowel Syndrome (SBS) Drugs Players Sales Volume Ranking (2023)
    2.4 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Short Bowel Syndrome (SBS) Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Short Bowel Syndrome (SBS) Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Short Bowel Syndrome (SBS) Drugs
    2.9 Short Bowel Syndrome (SBS) Drugs Market Competitive Analysis
        2.9.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Short Bowel Syndrome (SBS) Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Glucagon-Like Peptide-2 (GLP-2)
        3.1.2 Growth Hormone
        3.1.3 Glutamine
        3.1.4 Other
    3.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type
        3.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type
        3.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Short Bowel Syndrome (SBS) Drugs Average Price by Type (2019-2030)

 4 Segmentation by Sale Channel
    4.1 Introduction by Sale Channel
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Retail Pharmacies
    4.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel
        4.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030)
        4.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Sale Channel (2019-2030)
        4.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Value, by Sale Channel (%) (2019-2030)
    4.3 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel
        4.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030)
        4.3.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Sale Channel (2019-2030)
        4.3.3 Global Short Bowel Syndrome (SBS) Drugs Sales Volume, by Sale Channel (%) (2019-2030)
    4.4 Global Short Bowel Syndrome (SBS) Drugs Average Price by Sale Channel (2019-2030)

 5 Segmentation by Region
    5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region
        5.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region
        5.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        5.4.2 North America Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        5.5.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        5.7.2 South America Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value
        6.2.1 Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.3.2 United States Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.4.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.5 China
        6.5.1 China Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.5.2 China Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.6.2 Japan Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.7.2 South Korea Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030
    6.9 India
        6.9.1 India Short Bowel Syndrome (SBS) Drugs Sales Value, 2019-2030
        6.9.2 India Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel, 2023 VS 2030

 7 Company Profiles
    7.1 Merck
        7.1.1 Merck Company Information
        7.1.2 Merck Introduction and Business Overview
        7.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.1.5 Merck Recent Development
    7.2 Takeda
        7.2.1 Takeda Company Information
        7.2.2 Takeda Introduction and Business Overview
        7.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.2.5 Takeda Recent Development
    7.3 Emmaus Medical
        7.3.1 Emmaus Medical Company Information
        7.3.2 Emmaus Medical Introduction and Business Overview
        7.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.3.5 Emmaus Medical Recent Development
    7.4 Ardelyx
        7.4.1 Ardelyx Company Information
        7.4.2 Ardelyx Introduction and Business Overview
        7.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.4.5 Ardelyx Recent Development
    7.5 Naia Pharmaceuticals
        7.5.1 Naia Pharmaceuticals Company Information
        7.5.2 Naia Pharmaceuticals Introduction and Business Overview
        7.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.5.5 Naia Pharmaceuticals Recent Development
    7.6 Nutrinia
        7.6.1 Nutrinia Company Information
        7.6.2 Nutrinia Introduction and Business Overview
        7.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.6.5 Nutrinia Recent Development
    7.7 OxThera
        7.7.1 OxThera Company Information
        7.7.2 OxThera Introduction and Business Overview
        7.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.7.5 OxThera Recent Development
    7.8 Sancilio Pharmaceuticals
        7.8.1 Sancilio Pharmaceuticals Company Information
        7.8.2 Sancilio Pharmaceuticals Introduction and Business Overview
        7.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.8.5 Sancilio Pharmaceuticals Recent Development
    7.9 Zealand Pharma
        7.9.1 Zealand Pharma Company Information
        7.9.2 Zealand Pharma Introduction and Business Overview
        7.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Offerings
        7.9.5 Zealand Pharma Recent Development

 8 Industry Chain Analysis
    8.1 Short Bowel Syndrome (SBS) Drugs Industrial Chain
    8.2 Short Bowel Syndrome (SBS) Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Short Bowel Syndrome (SBS) Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Short Bowel Syndrome (SBS) Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Short Bowel Syndrome (SBS) Drugs Market Trends
    Table 2. Short Bowel Syndrome (SBS) Drugs Market Drivers & Opportunity
    Table 3. Short Bowel Syndrome (SBS) Drugs Market Challenges
    Table 4. Short Bowel Syndrome (SBS) Drugs Market Restraints
    Table 5. Global Short Bowel Syndrome (SBS) Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Short Bowel Syndrome (SBS) Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Short Bowel Syndrome (SBS) Drugs Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Short Bowel Syndrome (SBS) Drugs
    Table 13. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (2019-2024) & (US$ Million)
    Table 30. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (2025-2030) & (US$ Million)
    Table 31. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel (2019-2024) & (%)
    Table 32. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel (2025-2030) & (%)
    Table 33. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel (2019-2024) & (K Pcs)
    Table 35. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel (2025-2030) & (K Pcs)
    Table 36. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel (2019-2024) & (%)
    Table 37. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel (2025-2030) & (%)
    Table 38. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2019-2024) & (USD/Pcs)
    Table 39. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2025-2030) & (USD/Pcs)
    Table 40. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Short Bowel Syndrome (SBS) Drugs Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. Merck Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 61. Merck Recent Development
    Table 62. Takeda Company Information
    Table 63. Takeda Introduction and Business Overview
    Table 64. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. Takeda Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 66. Takeda Recent Development
    Table 67. Emmaus Medical Company Information
    Table 68. Emmaus Medical Introduction and Business Overview
    Table 69. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 71. Emmaus Medical Recent Development
    Table 72. Ardelyx Company Information
    Table 73. Ardelyx Introduction and Business Overview
    Table 74. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Ardelyx Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 76. Ardelyx Recent Development
    Table 77. Naia Pharmaceuticals Company Information
    Table 78. Naia Pharmaceuticals Introduction and Business Overview
    Table 79. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 81. Naia Pharmaceuticals Recent Development
    Table 82. Nutrinia Company Information
    Table 83. Nutrinia Introduction and Business Overview
    Table 84. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Nutrinia Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 86. Nutrinia Recent Development
    Table 87. OxThera Company Information
    Table 88. OxThera Introduction and Business Overview
    Table 89. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. OxThera Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 91. OxThera Recent Development
    Table 92. Sancilio Pharmaceuticals Company Information
    Table 93. Sancilio Pharmaceuticals Introduction and Business Overview
    Table 94. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 96. Sancilio Pharmaceuticals Recent Development
    Table 97. Zealand Pharma Company Information
    Table 98. Zealand Pharma Introduction and Business Overview
    Table 99. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Offerings
    Table 101. Zealand Pharma Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Short Bowel Syndrome (SBS) Drugs Downstream Customers
    Table 105. Short Bowel Syndrome (SBS) Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Short Bowel Syndrome (SBS) Drugs Product Picture
    Figure 2. Global Short Bowel Syndrome (SBS) Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Short Bowel Syndrome (SBS) Drugs Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Short Bowel Syndrome (SBS) Drugs Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Short Bowel Syndrome (SBS) Drugs Report Years Considered
    Figure 7. Global Short Bowel Syndrome (SBS) Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Short Bowel Syndrome (SBS) Drugs Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Short Bowel Syndrome (SBS) Drugs Revenue in 2023
    Figure 10. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Glucagon-Like Peptide-2 (GLP-2) Picture
    Figure 12. Growth Hormone Picture
    Figure 13. Glutamine Picture
    Figure 14. Other Picture
    Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Short Bowel Syndrome (SBS) Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 18. Global Short Bowel Syndrome (SBS) Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2019-2030) & (USD/Pcs)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Retail Pharmacies
    Figure 23. Global Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Short Bowel Syndrome (SBS) Drugs Sales Value Market Share by Sale Channel, 2023 & 2030
    Figure 25. Global Short Bowel Syndrome (SBS) Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 26. Global Short Bowel Syndrome (SBS) Drugs Sales Volume Market Share by Sale Channel, 2023 & 2030
    Figure 27. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2019-2030) & (USD/Pcs)
    Figure 28. North America Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Short Bowel Syndrome (SBS) Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 43. Europe Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 46. China Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 49. Japan Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 52. South Korea Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 55. Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 58. India Short Bowel Syndrome (SBS) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Short Bowel Syndrome (SBS) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Short Bowel Syndrome (SBS) Drugs Sales Value by Sale Channel (%), 2023 VS 2030
    Figure 61. Short Bowel Syndrome (SBS) Drugs Industrial Chain
    Figure 62. Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

The global market for Short Bowel Syndrome (SBS) Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome (SBS) Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Short Bowel Syndrome (SBS) Drugs by region & country, by Type, and by Sale Channel.

The Short Bowel Syndrome (SBS) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome (SBS) Drugs.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in country level. It provides sigmate data by Type, and by Sale Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.